About this item
Product details
Bozpah 62.5 mg from Nabiqasim contains Bosentan Monohydrate, a dual endothelin receptor antagonist (ERA). It is a specialized medication used for the treatment of Pulmonary Arterial Hypertension (PAH), a severe and progressive condition characterized by high blood pressure in the arteries of the lungs. Bozpah works by blocking the effects of endothelin, a potent substance that causes blood vessels to narrow. By blocking endothelin, it helps to relax and widen the pulmonary arteries, reducing the pressure in the lungs and improving exercise capacity. Targeted PAH Treatment: Specifically designed to treat World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension. Improves Exercise Ability: Helps patients with PAH to walk further and perform daily activities with less shortness of breath. Dual Receptor Blockade: Blocks both endothelin-A and endothelin-B receptors for comprehensive vasodilation. Oral Convenience: Provides an effective oral treatment option for a condition that often requires complex therapies. Symptom Management: Aids in reducing symptoms like breathlessness, fatigue, and chest pain. Composition Each tablet contains: Bosentan Monohydrate: 62.5 mg Suggested Usage As directed by the physician
- Medicines
- 10 Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Nabiqasim
- SKU
- 00665
- Variant
- 10 Tablets
- Tags
- Bosentan Monohydrate, Medicine
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
